Making informed decisions about prostate cancer testing: locally tailored factsheets on the burden of prostate cancer in Australia

Karen Chiam; Jane Crowe; Paul Grogan; Pavla Vaneckova; Ankur Kohar; Carolyn Mazariego; Visalini Nair-Shalliker; David P. Smith

doi:10.31128/AJGP-07-22-6500

Making informed decisions about prostate cancer testing: locally tailored factsheets on the burden of prostate cancer in Australia

Karen Chiam^*, Jane Crowe, Paul Grogan, Pavla Vaneckova, Ankur Kohar, Carolyn Mazariego, Visalini Nair-Shalliker, David P. Smith

^*Corresponding author for this work

Macquarie Medical School

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

PROSTATE-SPECIFIC ANTIGEN (PSA) testing for the early detection of prostate cancer has been a contentious topic for several decades. Evidence suggests that PSA testing is unlikely to be suitable as a population-based screening program due to inconsistent information relating to the relative benefits and harms of testing on mortality. A shared informed decisionmaking consultation between men and their general practitioners (GPs) to discuss the benefits and risks of PSA testing is required.

Original language	English
Pages (from-to)	102-105
Number of pages	4
Journal	Australian Journal of General Practice
Volume	52
Issue number	3
DOIs	https://doi.org/10.31128/AJGP-07-22-6500
Publication status	Published - Mar 2023

Access to Document

10.31128/AJGP-07-22-6500

Cite this

@article{d797285f4d894de1801573fa94266d25,

title = "Making informed decisions about prostate cancer testing: locally tailored factsheets on the burden of prostate cancer in Australia",

abstract = "PROSTATE-SPECIFIC ANTIGEN (PSA) testing for the early detection of prostate cancer has been a contentious topic for several decades. Evidence suggests that PSA testing is unlikely to be suitable as a population-based screening program due to inconsistent information relating to the relative benefits and harms of testing on mortality. A shared informed decisionmaking consultation between men and their general practitioners (GPs) to discuss the benefits and risks of PSA testing is required.",

author = "Karen Chiam and Jane Crowe and Paul Grogan and Pavla Vaneckova and Ankur Kohar and Carolyn Mazariego and Visalini Nair-Shalliker and Smith, \{David P.\}",

year = "2023",

month = mar,

doi = "10.31128/AJGP-07-22-6500",

language = "English",

volume = "52",

pages = "102--105",

journal = "Australian Journal of General Practice",

issn = "2208-794X",

publisher = "Royal Australian College of General Practitioners",

number = "3",

}

TY - JOUR

T1 - Making informed decisions about prostate cancer testing

T2 - locally tailored factsheets on the burden of prostate cancer in Australia

AU - Chiam, Karen

AU - Crowe, Jane

AU - Grogan, Paul

AU - Vaneckova, Pavla

AU - Kohar, Ankur

AU - Mazariego, Carolyn

AU - Nair-Shalliker, Visalini

AU - Smith, David P.

PY - 2023/3

Y1 - 2023/3

N2 - PROSTATE-SPECIFIC ANTIGEN (PSA) testing for the early detection of prostate cancer has been a contentious topic for several decades. Evidence suggests that PSA testing is unlikely to be suitable as a population-based screening program due to inconsistent information relating to the relative benefits and harms of testing on mortality. A shared informed decisionmaking consultation between men and their general practitioners (GPs) to discuss the benefits and risks of PSA testing is required.

AB - PROSTATE-SPECIFIC ANTIGEN (PSA) testing for the early detection of prostate cancer has been a contentious topic for several decades. Evidence suggests that PSA testing is unlikely to be suitable as a population-based screening program due to inconsistent information relating to the relative benefits and harms of testing on mortality. A shared informed decisionmaking consultation between men and their general practitioners (GPs) to discuss the benefits and risks of PSA testing is required.

UR - https://www.scopus.com/pages/publications/85149501323

U2 - 10.31128/AJGP-07-22-6500

DO - 10.31128/AJGP-07-22-6500

M3 - Article

C2 - 36872086

AN - SCOPUS:85149501323

SN - 2208-794X

VL - 52

SP - 102

EP - 105

JO - Australian Journal of General Practice

JF - Australian Journal of General Practice

IS - 3

ER -

Making informed decisions about prostate cancer testing: locally tailored factsheets on the burden of prostate cancer in Australia

Abstract

Access to Document

Other files and links

Fingerprint

Cite this